Search Results 101-110 of 28567 for Crohns disease
... Crohn's disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.
The purpose of this study is to test the effectiveness and safety of an experimental medication GED-0301 (mongersen) in patients who have active Crohn's disease ...
The purpose of this study is to compare the effectiveness of ultrasound with magnetic resonance (MR) enterography in the diagnosing and monitoring of Crohn's ...
Five individuals with inflammatory bowel disease (IBD) and obesity experienced effective weight loss after endoscopic bariatric therapy (EBT). April 21, 2023 ...
... Crohn's disease who were previously enrolled in the etrolizumab Phase III Study GA29144. ... Participant eligibility includes age, gender, type and stage of ...
The purpose of this study is to demonstrate the impact of an Adult Inflammatory Bowel Disease (IBD) learning health system approach that enables patients and ...
Clinical Trials · A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease · More about research at Mayo Clinic · Mayo Clinic Footer.
Patients of either gender ≥ 18 years and ≤ 75 years of age. Patients with Crohn's Disease (CD) diagnosed at least 6 months prior to Screening visit in ...
... Crohn's Disease (CD) and Ulcerative Colitis (UC) within the Pediatric Population ... Participant eligibility includes age, gender, type and stage of disease, and ...
The purpose of this study is to evaluate the effectiveness, safety and tolerability of TD-1473 in subjects with moderately-to-severely active Crohn's Disease ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.